| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |